Healthcare Innovation: A Surge of Venture Capital in Medical Technology

From AI-Powered Diagnostics to Aging Care, Startups Secure Over $500 Million in Funding Across Diverse Medical Sectors

FUNDING

AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics in Sydney, Australia, closed a US$112m Series C financing. The round was co-led by?SV Health Investors, Sanofi Ventures, Abingworth, and SymBiosis. Existing investor Morningside participated, as did new investors Tenmile, Brandon Capital, and others.

Helicore Biopharma, a San Francisco startup developing treatments for obesity and related health issues, raised a $65 million Series A round co-led by?Versant Ventures?and?OrbiMed, with?Longitude Capital?and?@Wellington.

Rad AI, a San Francisco, CA-based healthcare AI company, raised $60M in Series C funding at a $525M valuation. The round was led by Transformation Capital, with participation from existing investors Khosla Ventures, WiL (World Innovation Lab), UP2398, Kickstart Fund, OCV, Cone Health, and others.

Quibim, a Spanish startup developing foundational AI models for medical imaging spanning oncology, immunology, neurology, and metabolic disorders, has?raised $50 million?in a Series A round of funding. Quibim’s Series A round was led by?Spanish venture capital firm Asabys Partners?and private equity firm?Buenavista Equity Partners (formerly GED Capital), with participation from a slew of institutional and individual investors, including Amadeus Capital Partners, APEX Ventures, Partech, and iPod and iPhone co-creator?Tony Fadell.

SafelyYou, a San Francisco, CA-based company specializing in empowering care across senior living through AI, hardware, and remote expert clinicians, raised $43M in Series C funding. The round, which brought the total amount to $100M, was led by?Touring Capital?and participated in by?Foundation Capital,?Omega Healthcare Investors,?Founders Fund,?Cross Creek,?Samsung Next, and Qualcomm Ventures.

VideaHealth, a Boston, MA-based dental AI company, raised $40M in Series B funding. Emily Melton led the round, which included participation from Avenir Ventures, BAM Ventures, and existing investors Spark Capital, Zetta Venture Partners, and Pillar VC.

Amplitude Vascular Systems, a six-year-old Boston startup that has developed a device that uses high-frequency pulsatile pressure waves to fracture arterial calcium, aiming to restore blood flow in affected arteries, raised a $36 million round co-led by?BioStar Capital?and?CUE Growth Partners.

The Helper Bees, an Austin, TX-based provider of a technology aging platform, raised $35M in Series C funding. Centana Growth Partners led the round, which included participation from existing investors, including Silverton Partners, Impact Engine, Northwestern Mutual Future Ventures, and Alumni Ventures. The Helper Bees is an independent aging platform. Its technology allows insurers to close the care gap and empower older adults to remain in their homes for as long as possible. The company launched?helpful?,?a flexible spending card designed to transform how benefits are accessed and utilized, which simplifies payments for caregivers, service providers, and payers by providing a unified platform for retail and online product purchases and essential services.

Nobi, an AgeTech company based in Antwerpen, Belgium, raised €35M in Series B funding. Angelini Ventures and Nexus NeuroTech Ventures co-led the round, which was participated in by 15th Rock, existing investors EQT Health Economics and EQT Dementia Fund, PMV, and Nobi’s founders, Roeland Pelgrims, Bert De Haes, and Balz Halter.

Hone Health, an eight-year-old New York startup that operates an online clinic specializing in preventive and proactive longevity care for both men and women, raised a $33 million Series A round. Investors included?Tribe Capital, Public Investment Fund (PIF), Republic Capital, Vibe VC, humbition, Hanwha, Gaingels, Looking Glass Capital, FJ Labs, and?Agent Capital.?

KODE Health, an on-demand medical coding platform provider based in Holland, MI, raised $27M in Series B funding. The round was led by Noro-Moseley Partners and participated in by Mercury, FCA Venture Partners, Epsilon Innovation Fund, and 111° West Capital.

Delfina Care, a San Francisco, CA-based healthcare technology company, raised $17M in Series A funding. The round was led by USVP, with participation from new investors ARTIS Ventures, Mayo Clinic, and Tokio Marine Future Fund and existing investors, including Story Ventures, SemperVirens Venture Capital , Bread and Butter Ventures, Boutique Ventures, and?Chelsea Clinton’s?Metrodora Ventures.

Sound Blade Medical Inc., a Halifax, Nova Scotia, Canada-based medical device company developing handheld ultrasound-guided histotripsy technology, closed a US $16.5 million Series A funding round.?Amzak Health?and?Lumira Ventures?co-led the round, with participation from?Invest Nova Scotia.

Controversial genetics testing startup Nucleus Genomics raises $14M Series A. Investors like Alexis Ohanian’s Seven Seven Six 7??7??6??, Balaji Srinivasan, and SpaceX alum?Achal Upadhyaya participated.

C the Signs, a London, UK-based creator of an?Artificial Intelligence (AI)-based platform to identify patients at risk of cancer at the earliest and most curable stage, raised $8M in funding. Khosla Ventures led the round.

Waterlily, a San Francisco, CA-based startup that uses AI to predict long-term care (LTC) needs up to decades before they happen, closed a $7M seed funding round. John Kim, founding partner of Brewer Lane Ventures, led the round. Genworth, Nationwide, and Edward Jones participated, as did key industry leader Tim Kneeland (former CEO of GE Insurance & Transamerica LTC).

Aplagon, a clinical-stage biopharmaceutical company based in Helsinki, Finland, raised €7M in financing. New investors, the European Innovation Council (EIC) Fund, led the round, which Finnish investors, including Jenny and Antti Wihuri Foundation, Innovestor, and G?sta Serlachius Fine Arts Foundation, joined. The company intends to use the funds to support initiating a Phase 2a clinical trial of APAC for peripheral arterial occlusive disease/chronic limb-threatening ischemia (PAOD/CLTI) in Finland.

Medsender, a NYC-based provider of an AI-powered workflow automation platform for healthcare providers, raised $5M in Series A funding. Ballast Point Ventures led the round.

Sycai Technologies (dba Sycai Medical), a MedTech startup based in Barcelona, Spain, raised €3M in funding. Backers included LUMO Labs, Ship2B Ventures, Athos Capital, and Namarel Ventures.

Clarametyx Biosciences, a Columbus, OH-based clinical-stage company developing targeted immune-enabling biologic therapies to counter persistent infections associated with biofilms, received an investment from the Kinetics AMR Accelerator Fund. The deal amount, which extends the?Series A funding?completed in 2024, was not disclosed.

iotaMotion, a St. Paul, MN-based company developing advanced robotic-assisted systems for cochlear implant surgery, raised an undisclosed amount in Series B funding. Backers were not disclosed.

Suki, a company in Redwood City, CA, that develops artificial intelligence (AI) technology for healthcare, received an investment from Zoom Ventures. The amount of the deal was not disclosed.

Dxcover, a Glasgow, Scotland, UK-based clinical-stage diagnostics company, raised an undisclosed amount in funding. Backers included existing investors, as well as new investors, Macmillan Cancer Support and Maven Capital Partners. This brought the total funding raised to $21.4M since spinning out from the University of Strathclyde in 2019.